Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Ovarian Carcinoma

Phase 2 Active not recruiting 50 enrolled The First People's Hospital of Changzhou

Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether combining of radiofrequency ablation (RFA) and cytokine-induced killer cells (CIK) transfusion can prolong survival of patients with ovarian carcinoma.

Timeline

Start: 2015-07
Primary completion: 2038-06
Completion: 2040-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	CIK cells	Cell therapy	—	Intravenous

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Ovarian Carcinoma

Summary

Timeline

Drugs

Indications